OncoLize is preparing first clinical trials to treat pancreatic tumors. Based on solid Proof-of-Concept data and its proprietary OCL platform the company will raise €8.5 Million in two steps. This will start trials in the USA and EU. The round also establishes the pipeline of the same drugs for multiple tumor indications, next to scaling-up to early commercial scale.

Categories: Other

Leave a Reply

Your email address will not be published. Required fields are marked *